Delivery Order SPE2DE24D0021-SPE2D626F6392
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $8,250 fixed-price delivery order with economic price adjustment on October 29, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits with a completion date of December 29, 2025. The award represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Defense Department's Medical Supply Chain without a set-aside designation, indicating open competition. Fisher...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- Fisher Scientific Company L.L.C. was awarded a $1,100 fixed-price delivery order with economic price adjustment on September 23, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract is funded through the Medical Supply Chain division of the Defense agency and has a completion date of November 20, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract with no set-aside designation, indicating...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,450.00 for SOFIA Flu AB Test Kits (25 tests per pack) under a contract with the Department of Defense's Medical Supply Chain. The award, issued on October 23, 2025, carries an ultimate completion date of October 30, 2025, and utilizes fixed-price pricing with economic price adjustment terms. This delivery order represents a child contract under a larger procurement vehicle and involves no set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,423.36 on July 31, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price delivery order with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is scheduled for completion by September 26, 2025. The contract was awarded without a set-aside designation through open competition to the Medical Supply Chain, a defense-focused federal agency. As a...
- Fisher Scientific Company L.L.C. was awarded a $4,400 fixed-price delivery order with economic price adjustment authority for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies on September 4, 2025. The contract, which carries no set-aside designation, is a child award under a larger vehicle and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of October 31, 2025. The funding agency is the Department of Defense Medical...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent testing supplies. The award, issued on September 15, 2025, is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of November 12, 2025. The contract will be performed in Pittsburgh, Pennsylvania, and was funded through the Department of Defense's Medical Supply Chain division. No set-aside designation was...
- Fisher Scientific Company L.L.C. was awarded a delivery order by the Department of Defense's Medical Supply Chain on October 30, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The contract carries a ceiling value of $1,100 and employs fixed-price-with-economic-price-adjustment pricing without a set-aside designation, indicating open competition. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of December 30, 2025. This...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1.65K to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by October 22, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle structure, with no small...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F6392Delivery Order
Fisher Scientific Company L.L.C. was awarded a $4,400 fixed-price delivery order with economic price adjustment on October 29, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract is a child order under a larger indefinite delivery vehicle and carries an ultimate completion date of December 29, 2025. The award was issued by the Defense Medical Supply Chain, a defense-focused federal agency responsible for procuring medical and laboratory supplies for Department of Defense operations. No set-aside designation was used in this competitive procurement. Fisher Scientific, a Pittsburgh, Pennsylvania-based scientific products and medical supplies vendor, maintains extensive experience supplying diagnostic equipment and reagents to federal agencies across the Department of Defense, Department of Veterans Affairs, and various civilian health institutes. This delivery order supports the Defense Medical Supply Chain's need for rapid diagnostic testing capabilities, specifically for concurrent influenza and SARS-CoV-2 antigen detection. Fisher Scientific's established role as a primary supplier of laboratory diagnostics and medical consumables to federal healthcare operations positions the company to fulfill this critical supply requirement efficiently. The relatively modest contract value and compressed performance timeline indicate a routine replenishment of existing diagnostic inventory to support ongoing Department of Defense medical operations and pandemic preparedness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 10/29/25 |